This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,427.98 firm-fixed-price delivery order is for LINZESS 290 MCG CAPSULE UU 30S and has a completion date of February 19, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,849.83, is a Firm Fixed Price Delivery Order for the supply of LINZESS 290 MCG Capsules to support military healthcare programs. The contract has an ultimate completion date of July 1, 2024 and was awarded on June 28, 2024. This contract award is part of a larger Indefinite Delivery Contract...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order valued at $7,982.53 for the pharmaceutical product LINZESS 290 MCG CAPSULE UU 30S. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,017.18 firm fixed-price delivery order is for the supply of LINZESS 145 MCG CAPSULE UU 30S, a pharmaceutical product. The contract has an ultimate completion date of March 3, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $1,558.54, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for LINZESS 290 MCG CAPSULE UU 30S, a pharmaceutical product. The contract has an ultimate completion date of September 20, 2023 and is a firm fixed-price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,380.19 firm fixed-price delivery order is for the supply of the medication LINZESS 72 MCG CAPSULE UU 30S. The contract has an ultimate completion date of November 15, 2024 and does not have a set-aside designation. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,261.98 fixed-price delivery order is for the supply of LINZESS 145 MCG capsules and has an ultimate completion date of October 21, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,102.22 firm fixed-price delivery order is for the supply of LINZESS 145 MCG CAPSULE medical products, with a period of performance through November 4, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This...
This federal contract award, valued at $1,528.86, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for LINZESS 290 MCG CAPSULE UU 30S, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,945.17, is a delivery order for LINZESS 290 MCG CAPSULE UU 30S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of March 24, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...